Catheter ablation of atrioventricular nodal reentrant tachycardia, when AVNRT presented as a fetus or infant

Research output: Contribution to journalArticlepeer-review


Background: Atrioventricular nodal reentrant tachycardia (AVNRT) does not commonly present during infancy. Although relative safety of catheter ablation of AVNRT has been demonstrated in pediatrics, this procedure is rarely indicated in children <15 kg. Methods: Retrospective review of seven cases of AVNRT that presented in children younger than 1 year of age and required catheter ablation for definitive management. Electrophysiology (EP) study was planned with two or three catheters. Area of ablation determined by voltage mapping, propagation sinus wave collision and slow pathway potential location. Ablation performed with cryothermal energy. No fluoroscopy was used. Results: Presentation ranged from 36 weeks of gestation to 11 months of age. Two presented in fetal life and two in the neonatal period. The median age of ablation was 20 months (range 17–31 months). The median weight at ablation was 11.4 kg (range 8.9–14.9 kg). Median follow-up time was 16 months. All had typical AVNRT. The median tachycardia cycle length was 216 ms. 100% successful rate using cryoablation. No complications. No recurrence of tachycardia during the follow-up period. Conclusion: Slow AV nodal pathway cryoablation may be safely performed, with good short and medium-term outcomes in patients under 15 kg.

Original languageEnglish (US)
Pages (from-to)1310-1314
Number of pages5
JournalPACE - Pacing and Clinical Electrophysiology
Issue number11
StatePublished - Nov 2023

Bibliographical note

Publisher Copyright:
© 2023 The Authors. Pacing and Clinical Electrophysiology published by Wiley Periodicals LLC.


  • ablation
  • atrioventricular nodal reentrant tachycardia
  • cryoablation
  • pediatric
  • small children

PubMed: MeSH publication types

  • Journal Article


Dive into the research topics of 'Catheter ablation of atrioventricular nodal reentrant tachycardia, when AVNRT presented as a fetus or infant'. Together they form a unique fingerprint.

Cite this